Corline Biomedical AB (CLBIO.ST)

SEK 8.76

(5.29%)

Annual Income Statements

(In SEK)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 25.03 Million 23.55 Million 7.06 Million 3.69 Million 1.06 Million 1.56 Million
Cost of Revenue -3.35 Million 824 Thousand -2.04 Million -6.62 Million -6.08 Million -4.96 Million
Gross Profit 28.38 Million 22.72 Million 9.1 Million 10.32 Million 7.14 Million 6.52 Million
Operating Expenses 30.16 Million 20.39 Million 11.13 Million 17.6 Million 16.68 Million 13.32 Million
Selling, General and Administrative Expenses - 20.89 Million 15.94 Million 6.21 Million 16.69 Million 5.44 Million
Research and Development Expenses - - - - - -
Other Expenses 30.16 Million 20.39 Million 11.13 Million 11.38 Million 16.68 Million 7.87 Million
Cost and Expenses 26.81 Million 21.22 Million 9.09 Million 10.98 Million 10.6 Million 8.35 Million
Operating Income -1.78 Million 2.32 Million -6.9 Million -7.28 Million -9.54 Million -6.79 Million
Interest Expense 26 Thousand - 13 Thousand - - 1000.00
Income Tax Expense - 549 Thousand -6000.00 -84 Thousand 13 Thousand 1000.00
Earnings before Tax -1.8 Million 2.32 Million -6.92 Million -7.28 Million -9.54 Million -6.79 Million
Net Income -1.8 Million 2.32 Million -6.91 Million -7.28 Million -9.54 Million -6.79 Million
Earnings Per Share Basic -0.08 0.11 -0.34 -0.42 -0.57 -0.44
Earnings Per Share Diluted -0.08 0.11 -0.34 -0.42 -0.57 -0.44
Weighted Average Shares Outstanding 21.49 Million 21.49 Million 20.43 Million 17.14 Million 16.73 Million 15.58 Million
Weighted Average Shares Outstanding (Diluted) 21.67 Million 21.49 Million 20.43 Million 17.14 Million 16.73 Million 15.58 Million
Gross Margin 1.13 0.97 1.29 2.79 6.72 4.18
EBIT Margin -0.07 0.10 -0.97 -1.97 -8.96 -4.35
Profit Margin -0.07 0.10 -0.98 -1.97 -8.97 -4.35
EBITDA -1.69 Million 2.38 Million -6.87 Million -7.27 Million -9.53 Million -6.79 Million
Earnings Before Tax Margin -0.07 0.10 -0.98 -1.97 -8.97 -4.35

Income Statement Charts